A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya
about
Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malariaGenetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum ParasitesMultinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine.Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season.Comparing the impact of artemisinin-based combination therapies on malaria transmission in sub-Saharan AfricaImpact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria.A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013Accuracy of PfHRP2 versus Pf-pLDH antigen detection by malaria rapid diagnostic tests in hospitalized children in a seasonal hyperendemic malaria transmission area in Burkina FasoImpact of intermittent screening and treatment for malaria among school children in Kenya: a cluster randomised trial.New insight-guided approaches to detect, cure, prevent and eliminate malaria.The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine.Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveller coming from Ethiopia.Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
P2860
Q24201077-8816356C-29A0-437D-A145-8118DC6BBFA8Q28554000-778E5DF9-B783-410A-9BC5-73C44D00C56BQ35068138-E51D95D3-8EAA-45FD-BB9A-1DDF554B5011Q35101288-20A489BC-F84E-41D3-8E84-787380CAD696Q35150299-BFAD5B5C-26B4-4CC2-9FE8-54A0F8B39354Q35607844-69BC8750-1148-4991-A951-E0BE4A1AC97FQ35860066-1835100A-B5B8-40A7-A617-BC2171E9AFF2Q37089918-D9FACF64-9A1B-443B-B3D9-43306FB37247Q37497492-45F714DE-C95A-4B6A-BAC2-B783FE5CCB46Q37524994-40284AFD-0DC7-4666-8D99-831BA0B0E717Q38260909-B55EC5AF-53FD-4C20-97CD-1BF7BB230F64Q38529669-B0ACC89C-E90F-4645-BB1C-138B5ED57723Q39025693-C5801CCC-836A-4DF3-9CD7-235CFAA2F279Q58546525-83017D01-63B5-47D9-BAA8-656CA44BE44E
P2860
A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A randomized trial of artemeth ...... mong children in western Kenya
@en
A randomized trial of artemeth ...... ong children in western Kenya.
@nl
type
label
A randomized trial of artemeth ...... mong children in western Kenya
@en
A randomized trial of artemeth ...... ong children in western Kenya.
@nl
prefLabel
A randomized trial of artemeth ...... mong children in western Kenya
@en
A randomized trial of artemeth ...... ong children in western Kenya.
@nl
P2093
P2860
P50
P356
P1433
P1476
A randomized trial of artemeth ...... mong children in western Kenya
@en
P2093
Aarti Agarwal
John Williamson
Kephas Otieno
Meredith McMorrow
Peter Onyango
Simon Kariuki
Stephen Patrick Kachur
P2860
P2888
P356
10.1186/1475-2875-12-254
P577
2013-07-19T00:00:00Z
P5875
P6179
1021552487